The European guideline for the management of pelvic inflammatory disease includes
evidence-based advice on the investigation and treatment of pelvic inflammatory disease …

This guideline was produced by the European region of the International Union against
sexually transmitted infections (IUSTI) and refers to ascending infections in the female …

Pelvic inflammatory disease (PID) remains one of the most important consequences of
sexually transmitted infections (STIs) resulting in severe morbidity and acting as the …

Pelvic inflammatory disease (PID) is a gynaecological inflammatory disorder with a high
incidence that can lead to sequelae such as infertility, ectopic pregnancy and chronic pelvic …

Background: Pelvic inflammatory disease (PID) is one of the most common infections seen
in nonpregnant reproductive-age women. It is a major public health problem associated with …

Objective: This multinational, multicentre, prospective, randomised, double blind, parallel
group, non-inferiority study compared the efficacy and safety of moxifloxacin monotherapy …

Pelvic inflammatory disease (PID), one of the most common infections in non-pregnant
women of reproductive age, remains an important public health problem. It is associated …

Please cite this paper as: Judlin P, Liao Q, Liu Z, Reimnitz P, Hampel B, Arvis P. Efficacy and
safety of moxifloxacin in uncomplicated pelvic inflammatory disease: the MONALISA study …

Abstract Treatment of pelvic inflammatory disease (PID) should provide high rates of clinical
and microbiological cure for a range of pathogens and should ultimately prevent …

Pelvic inflammatory disease (PID), the infection and inflammation of the female upper genital
tract, is a common cause of infertility, chronic pain and ectopic pregnancy. Diagnosis and …